Richard Rowell

711 total citations
15 papers, 458 citations indexed

About

Richard Rowell is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Richard Rowell has authored 15 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Cardiology and Cardiovascular Medicine and 4 papers in Epidemiology. Recurrent topics in Richard Rowell's work include Liver Disease and Transplantation (3 papers), Psoriasis: Treatment and Pathogenesis (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). Richard Rowell is often cited by papers focused on Liver Disease and Transplantation (3 papers), Psoriasis: Treatment and Pathogenesis (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). Richard Rowell collaborates with scholars based in United States, Germany and Argentina. Richard Rowell's co-authors include Mark E. Alexander, Linda L Remy, Kevin Grumbach, B.M. Massie, Kent W. Dauterman, Alan S. Go, Barry M. Massie, Sharmeen Gettner, Tebeb Gebretsadik and Daniel J. Pearce and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Heart Journal and Clinical Gastroenterology and Hepatology.

In The Last Decade

Richard Rowell

15 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard Rowell United States 11 203 108 51 51 49 15 458
Frances Boa United Kingdom 7 419 2.1× 66 0.6× 123 2.4× 5 0.1× 20 0.4× 16 685
Sérgio Gardano Elias Bucharles Brazil 12 169 0.8× 94 0.9× 92 1.8× 3 0.1× 20 0.4× 29 638
Lauren Weaver United States 8 24 0.1× 107 1.0× 58 1.1× 14 0.3× 23 0.5× 25 470
Houli Wang China 8 52 0.3× 102 0.9× 80 1.6× 6 0.1× 4 0.1× 13 480
Sanjay D’Cruz India 15 43 0.2× 76 0.7× 203 4.0× 16 0.3× 10 0.2× 63 650
M G Bramble United Kingdom 19 45 0.2× 176 1.6× 422 8.3× 41 0.8× 67 1.4× 49 924
Roger Gabriel United Kingdom 11 99 0.5× 78 0.7× 121 2.4× 7 0.1× 12 0.2× 33 402
Juliette Tavenier Denmark 12 30 0.1× 100 0.9× 52 1.0× 4 0.1× 52 1.1× 29 370
Wadie M. Elmadhoun Sudan 15 90 0.4× 177 1.6× 41 0.8× 5 0.1× 24 0.5× 35 594
Caner Çavdar Türkiye 14 20 0.1× 69 0.6× 45 0.9× 6 0.1× 20 0.4× 64 546

Countries citing papers authored by Richard Rowell

Since Specialization
Citations

This map shows the geographic impact of Richard Rowell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Rowell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Rowell more than expected).

Fields of papers citing papers by Richard Rowell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Rowell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Rowell. The network helps show where Richard Rowell may publish in the future.

Co-authorship network of co-authors of Richard Rowell

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Rowell. A scholar is included among the top collaborators of Richard Rowell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Rowell. Richard Rowell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Irving, Melita, William R. Wilcox, Carlos A. Bacino, et al.. (2024). Persistent growth-promoting effects of vosoritide in children with achondroplasia are accompanied by improvements in physical and social aspects of health-related quality of life. Genetics in Medicine. 26(12). 101274–101274. 5 indexed citations
3.
Llerena, Juan Clinton, Débora Romeo Bertola, Mariana del Pino, et al.. (2023). Lifetime Impact Study for Achondroplasia (LISA): Findings from an observational and multinational study focused on health-related quality of life in individuals with achondroplasia in Latin America. SHILAP Revista de lepidopterología. 2. 100843–100843. 1 indexed citations
4.
Waisbren, Susan E., Barbara K. Burton, Annette Feigenbaum, et al.. (2021). Long-term preservation of intellectual functioning in sapropterin-treated infants and young children with phenylketonuria: A seven-year analysis. Molecular Genetics and Metabolism. 132(2). 119–127. 11 indexed citations
5.
Zori, Roberto T., Kirsten Ahring, Barbara K. Burton, et al.. (2019). Long-term comparative effectiveness of pegvaliase versus standard of care comparators in adults with phenylketonuria. Molecular Genetics and Metabolism. 128(1-2). 92–101. 19 indexed citations
6.
Landis, Charles, Marwan Ghabril, Vinod K. Rustgi, et al.. (2016). Prospective Multicenter Observational Study of Overt Hepatic Encephalopathy. Digestive Diseases and Sciences. 61(6). 1728–1734. 10 indexed citations
7.
Jurek, Marzena, Masoud Mokhtarani, John M. Vierling, et al.. (2016). Variation in Liver Biochemistries in Patients with Decompensated Cirrhosis: Implications for Assessing Drug-Induced Liver Injury in Clinical Trials. Pharmaceutical Medicine. 30(2). 95–101. 2 indexed citations
8.
Vierling, John M., Masoud Mokhtarani, Robert S. Brown, et al.. (2015). Fasting Blood Ammonia Predicts Risk and Frequency of Hepatic Encephalopathy Episodes in Patients With Cirrhosis. Clinical Gastroenterology and Hepatology. 14(6). 903–906.e1. 48 indexed citations
9.
Dabade, Tushar S., et al.. (2011). Efficacy of low-dose acitretin in the treatment of psoriasis. Journal of Dermatological Treatment. 23(6). 400–403. 10 indexed citations
10.
Weiß, Stefan, Richard Rowell, & Lincoln Krochmal. (2008). Impact of seasonality on conducting clinical studies in dermatology. Clinics in Dermatology. 26(5). 565–569. 20 indexed citations
11.
Elewski, Boni E., William Abramovits, Steven Kempers, et al.. (2007). A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions.. PubMed. 6(10). 1001–8. 32 indexed citations
12.
Pearce, Daniel J., et al.. (2006). Low-Dose Acitretin Is Associated With Fewer Adverse Events Than High-Dose Acitretin in the Treatment of Psoriasis. Archives of Dermatology. 142(8). 1000–4. 38 indexed citations
13.
Alexander, Mark E., Laurence C. Baker, Cheryl R. Clark, et al.. (2002). Management of ventricular arrhythmias in diverse populations in California. American Heart Journal. 144(3). 431–439. 15 indexed citations
14.
Dauterman, Kent W., Alan S. Go, Richard Rowell, et al.. (2001). Congestive heart failure with preserved systolic function in a statewide sample of community hospitals. Journal of Cardiac Failure. 7(3). 221–228. 62 indexed citations
15.
Alexander, Mark E., Kevin Grumbach, Linda L Remy, Richard Rowell, & B.M. Massie. (1999). Congestive heart failure hospitalizations and survival in California: Patterns according to race/ethnicity. American Heart Journal. 137(5). 919–927. 179 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026